FDA approved Opdivo (nivolumab) to treat patients with non-squamous, advanced non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy.
FDA has initiated the approval of leucovorin calcium tablets, rushing them to market as part of a push from the Trump administration to identify potential treatments for autism spectrum disorder.
